ORCID

Información ORCID de GIRON GONZALEZ, JOSE ANTONIO

Biografía

Nacido el 10/4/1958 en Maracena (Granada, España)\nResidente actualmente en Cádiz, España

Educación

Máster en Enfermedades Infecciosas

Universidad de Sevilla: Seville, Andalucía, España

01/10/2012 hasta 15/07/2013

Doctor en Medicina

Universidad de Granada Facultad de Medicina: Granada, Andalucía, España

22/05/1988

Especialista en Medicina Interna (Medicina Interna)

Clínica Puerta de Hierro, Madrid: Madrid, ", , España

07/01/1983 hasta 06/01/1988

Licenciatura de Medicina y Cirugía

Universidad de Granada Facultad de Medicina: Granada, Andalucía, España

01/10/1975 hasta 01/07/1981

Empleo

Jefe de Servicio (Medicina Interna)

Hospital Universitario Puerta del Mar: Cádiz, Andalucía, España

01/10/2013

Catedrático de Universidad (Medicina)

Universidad de Cádiz Facultad de Medicina: Cádiz , Andalucía, España

29/12/2009

Facultativo Especialista (Medicina Interna)

Hospital Universitario Puerta del Mar: Cádiz, Andalucía, España

01/10/1991 hasta 01/10/2013

Profesor Titular de Universidad (Medicina)

Universidad de Cádiz Facultad de Medicina: Cádiz, ", , España

01/10/1991 hasta 28/12/2009

Facultativo Especialista (Medicina Interna)

Hospital Comarcal Infanta Elena: Huelva, Andalucía, España

02/02/1990 hasta 30/09/1991

Facultativo Especialista (Medicina Interna)

Hospital Severo Ochoa: Leganés, Madrid, España

08/01/1988 hasta 26/01/1990

Obras

Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

2022 | JOURNAL_ARTICLE

DOI: 10.3390/biomedicines10102638

Mostrar Detalles

Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

2021 | JOURNAL_ARTICLE

DOI: 10.1007/s10096-021-04237-y

Mostrar Detalles

Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

2019 | JOURNAL_ARTICLE

DOI: 10.1007/s11481-018-09832-z

Mostrar Detalles

Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

2019 | JOURNAL_ARTICLE

DOI: 10.1007/s00277-019-03700-3

Mostrar Detalles

Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

2019 | JOURNAL_ARTICLE

DOI: 10.1038/s41598-019-48185-2

Mostrar Detalles

Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study

2018 | JOURNAL_ARTICLE

DOI: 10.1016/j.jinf.2018.08.014

Mostrar Detalles

Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections

2018 | JOURNAL_ARTICLE

DOI: 10.1111/cei.13201

Mostrar Detalles

**Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality**

2018 | JOURNAL_ARTICLE

DOI: 10.2147/IDR.S163944

Mostrar Detalles

Assessment of the Palliative Prognostic Index in hospitalized oncologic patients treated by a palliative care team: impact of acute concomitant diseases.

2018 | JOURNAL_ARTICLE

DOI: 10.18632/oncotarget.24826

Mostrar Detalles

Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock

2017 | JOURNAL_ARTICLE

DOI: 10.1371/journal.pone.0175254

Mostrar Detalles

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.

2016 | JOURNAL_ARTICLE

DOI: 10.1007/s10096-016-2822-6

Mostrar Detalles

Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

2016 | JOURNAL_ARTICLE

DOI: 10.3748/wjg.v22.i4.1433

Mostrar Detalles

Determination of glycosylated hemoglobin during hospitalization as an opportunity to assess and optimize glycemic control in our patients: An unresolved matter.

2015 | JOURNAL_ARTICLE

DOI: 10.1016/j.endonu.2015.09.001

Mostrar Detalles

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

2015 | JOURNAL_ARTICLE

DOI: 10.1007/s10096-015-2426-6

Mostrar Detalles

Acute Q fever and the risk of developing endocarditis.

2015 | JOURNAL_ARTICLE

DOI: 10.1016/j.rce.2015.01.011

Mostrar Detalles

Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.

2015 | JOURNAL_ARTICLE

DOI: 10.1371/journal.pone.0119568

Mostrar Detalles

Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

2014 | JOURNAL_ARTICLE

DOI: 10.1371/journal.pone.0101760

Mostrar Detalles

Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.

2014 | JOURNAL_ARTICLE

DOI: 10.1371/journal.pone.0097262

Mostrar Detalles

Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.

2014 | JOURNAL_ARTICLE

DOI: 10.1016/s1473-3099(13)70359-1

Mostrar Detalles

Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.

2013 | JOURNAL_ARTICLE

DOI: 10.1371/journal.pone.0066619

Mostrar Detalles

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.

2013 | JOURNAL_ARTICLE

DOI: 10.1093/cid/cit103

Mostrar Detalles

Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C.

2012 | JOURNAL_ARTICLE

DOI: 10.1089/aid.2012.0126

Mostrar Detalles

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

2012 | JOURNAL_ARTICLE

DOI: 10.1002/hep.25791

Mostrar Detalles

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.

2012 | JOURNAL_ARTICLE

DOI: 10.1093/cid/cis779

Mostrar Detalles

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

2012 | JOURNAL_ARTICLE

DOI: 10.1097/qad.0b013e3283568884

Mostrar Detalles

[Primary cutaneous nocardiosis caused by Nocardia farcinica].

2012 | JOURNAL_ARTICLE

DOI: 10.1016/j.rce.2012.02.015

Mostrar Detalles

[Use of an empirical antiretroviral treatment depends on the primary resistance rate of the human immunodeficiency virus].

2012 | JOURNAL_ARTICLE

DOI: 10.1016/j.eimc.2011.12.007

Mostrar Detalles

[Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients].

2011 | JOURNAL_ARTICLE

DOI: 10.1016/j.eimc.2011.07.005

Mostrar Detalles

Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.

2011 | JOURNAL_ARTICLE

DOI: 10.1097/qai.0b013e31820ef408

Mostrar Detalles

Hepatocyte growth factor and chronic hepatitis C.

2010 | JOURNAL_ARTICLE

Mostrar Detalles

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

2009 | JOURNAL_ARTICLE

DOI: 10.1086/605676

Mostrar Detalles

Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.

2009 | JOURNAL_ARTICLE

DOI: 10.1080/03009740902973821

Mostrar Detalles

[Neurocognitive impairment related to acquired immunodeficiency syndrome in socially-excluded former intravenous drug abusers].

2009 | JOURNAL_ARTICLE

DOI: 10.1016/j.eimc.2009.05.007

Mostrar Detalles

Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.

2009 | JOURNAL_ARTICLE

DOI: 10.1111/j.1365-2249.2009.04005.x

Mostrar Detalles

Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.

2009 | JOURNAL_ARTICLE

DOI: 10.1016/j.cellimm.2009.05.013

Mostrar Detalles

An elderly woman with Prevotella bacteraemia secondary to pyometra.

2009 | JOURNAL_ARTICLE

DOI: 10.1136/bcr.09.2008.0897

Mostrar Detalles

Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.

2008 | JOURNAL_ARTICLE

DOI: 10.1177/0269216308098803

Mostrar Detalles

[Progressive multifocal leukoencephalopathy in the province of Cadiz, Spain]

2008 | JOURNAL_ARTICLE

Mostrar Detalles

Bilateral pneumonia by Mycobacterium aurum in a patient receiving infliximab therapy.

2008 | JOURNAL_ARTICLE

DOI: 10.1016/j.jinf.2008.04.010

Mostrar Detalles

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

2008 | JOURNAL_ARTICLE

DOI: 10.1093/jac/dkn262

Mostrar Detalles

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

2007 | JOURNAL_ARTICLE

DOI: 10.1093/jac/dkm373

Mostrar Detalles

[Renal failure and insulin resistance: effect of the dialysis dose]

2007 | JOURNAL_ARTICLE

DOI: 10.1157/13109833

Mostrar Detalles

[Clinical and therapeutic management of respiratory tract infections. Consensus document of the Andalusian Infectious Diseases Society and the Andalusian Family and Community Medicine Society].

2007 | JOURNAL_ARTICLE

DOI: 10.1157/13100467

Mostrar Detalles

Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study.

2007 | JOURNAL_ARTICLE

Mostrar Detalles

Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.

2007 | JOURNAL_ARTICLE

Mostrar Detalles

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.

2007 | JOURNAL_ARTICLE

Mostrar Detalles

What length of follow-up in patients with HIV and hepatitis C virus coinfection is necessary to consider the level of transaminases to be "persistently normal"?

2007 | JOURNAL_ARTICLE

DOI: 10.1086/510493

Mostrar Detalles

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.

2006 | JOURNAL_ARTICLE

DOI: 10.1089/aid.2006.22.1236

Mostrar Detalles

T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.

2006 | JOURNAL_ARTICLE

DOI: 10.1111/j.1365-2249.2006.03220.x

Mostrar Detalles

Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.

2006 | JOURNAL_ARTICLE

DOI: 10.1093/jac/dkl214

Mostrar Detalles

Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.

2006 | JOURNAL_ARTICLE

DOI: 10.1111/j.1365-2893.2005.00679.x

Mostrar Detalles

Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha.

2006 | JOURNAL_ARTICLE

DOI: 10.1089/aid.2006.22.307

Mostrar Detalles

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.

2006 | JOURNAL_ARTICLE

Mostrar Detalles

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.

2006 | JOURNAL_ARTICLE

DOI: 10.1097/01.aids.0000198087.47454.e1

Mostrar Detalles

Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.

2005 | JOURNAL_ARTICLE

Mostrar Detalles

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.

2005 | JOURNAL_ARTICLE

DOI: 10.1136/gut.2005.065904

Mostrar Detalles

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

2005 | JOURNAL_ARTICLE

DOI: 10.1002/hep.20626

Mostrar Detalles

Adhesion molecules as a prognostic marker of liver cirrhosis.

2005 | JOURNAL_ARTICLE

DOI: 10.1080/00365520510011470

Mostrar Detalles

[Admissions and mortality changes in a third-level care Hospital Internal Medicine Department (1996-2000). Influence of the modifications in the HIV infection treatment]

2005 | JOURNAL_ARTICLE

DOI: 10.1157/13072495

Mostrar Detalles

Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.

2005 | JOURNAL_ARTICLE

DOI: 10.1111/j.1469-0691.2004.01033.x

Mostrar Detalles

Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.

2004 | JOURNAL_ARTICLE

DOI: 10.1111/j.1469-0691.2004.01023.x

Mostrar Detalles

Implication of inflammation-related cytokines in the natural history of liver cirrhosis.

2004 | JOURNAL_ARTICLE

DOI: 10.1111/j.1478-3231.2004.0951.x

Mostrar Detalles

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

2004 | JOURNAL_ARTICLE

Mostrar Detalles

Orofacial infections of odontogenic origin.

2004 | JOURNAL_ARTICLE

Mostrar Detalles

[The interconsultation of surgical services: a mission for the internist]

2004 | JOURNAL_ARTICLE

DOI: 10.1157/13063523

Mostrar Detalles

Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome.

2004 | JOURNAL_ARTICLE

DOI: 10.1136/ard.2003.010694

Mostrar Detalles

Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.

2004 | JOURNAL_ARTICLE

DOI: 10.1002/jmv.20045

Mostrar Detalles

Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes.

2004 | JOURNAL_ARTICLE

DOI: 10.1007/s10096-003-1099-8

Mostrar Detalles

[Treatment of the infections by enterococcus]

2003 | JOURNAL_ARTICLE

DOI: 10.1016/s0014-2565(03)71333-2

Mostrar Detalles

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.

2003 | JOURNAL_ARTICLE

DOI: 10.1086/367643

Mostrar Detalles

Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus.

2002 | JOURNAL_ARTICLE

DOI: 10.1046/j.1469-0691.2002.00437.x

Mostrar Detalles

[Infections by Arcanobacterium haemolyticum: an emerging pathogen]

2002 | JOURNAL_ARTICLE

Mostrar Detalles

Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV-infected patients.

2002 | JOURNAL_ARTICLE

DOI: 10.1007/s10096-002-0729-x

Mostrar Detalles

Dilutional hyponatremia in patients with cirrhosis and ascites.

2002 | JOURNAL_ARTICLE

DOI: 10.1001/archinte.162.3.323

Mostrar Detalles

[Clinical suspicion and diagnosis of aortitis]

2001 | JOURNAL_ARTICLE

DOI: 10.1016/s0014-2565(01)70955-1

Mostrar Detalles

Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.

2001 | JOURNAL_ARTICLE

DOI: 10.1023/a:1010645302750

Mostrar Detalles

Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis.

2001 | JOURNAL_ARTICLE

DOI: 10.1046/j.1365-2249.2001.01414.x

Mostrar Detalles

Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus.

2000 | JOURNAL_ARTICLE

DOI: 10.1136/heart.84.6.620

Mostrar Detalles

Detection of hepatitis G virus (HGV) RNA and antibodies to the HGV envelope protein E2 in a cohort of hemodialysis patients.

2000 | JOURNAL_ARTICLE

Mostrar Detalles

Effect of patient adherence to antiretroviral therapy on CD4+ cell count, HIV-1 RNA, and serum concentrations of tumor necrosis factor and its soluble receptors.

2000 | JOURNAL_ARTICLE

DOI: 10.1007/s100960000379

Mostrar Detalles

[Vaccinations in the patient infected with the human immunodeficiency virus].

2000 | JOURNAL_ARTICLE

Mostrar Detalles

Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women.

2000 | JOURNAL_ARTICLE

DOI: 10.1530/eje.0.1430031

Mostrar Detalles

[Serial assessment of the nutritional status of patients infected by the human immunodeficiency virus. Role of tumor necrosis factor/its receptors]

1999 | JOURNAL_ARTICLE

Mostrar Detalles

[A prospective study of meningitis diagnosed in a 3rd-level hospital during a 1-year period]

1999 | JOURNAL_ARTICLE

Mostrar Detalles

Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients.

1998 | JOURNAL_ARTICLE

Mostrar Detalles

[Vertebral osteomyelitis as an atypical presentation of pneumococcal infection in a patient with HIV infection]

1997 | JOURNAL_ARTICLE

Mostrar Detalles

Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study.

1997 | JOURNAL_ARTICLE

DOI: 10.1086/513628

Mostrar Detalles

Influence of CD4+ status on the invasiveness of pneumococcal pneumonia in HIV patients.

1996 | JOURNAL_ARTICLE

DOI: 10.1007/bf01690518

Mostrar Detalles

[Pain in the chin area as presentation form of myocardial ischemia]

1996 | JOURNAL_ARTICLE

Mostrar Detalles

[Aspergillus tracheobronchitis in a patient with AIDS]

1995 | JOURNAL_ARTICLE

Mostrar Detalles

[Ablation of the hyperconducting atrioventricular node in a patient with thyrotoxicosis induced by amiodarone]

1995 | JOURNAL_ARTICLE

Mostrar Detalles

T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferative response to polyclonal mitogens.

1994 | JOURNAL_ARTICLE

Mostrar Detalles

[Treatment of hyperthyroidism from Graves-Basedow's disease]

1993 | JOURNAL_ARTICLE

Mostrar Detalles

[Primary intestinal lymphoma of the western type. Retrospective study of 24 patients]

1988 | JOURNAL_ARTICLE

Mostrar Detalles

The association of non-Hodgkin's lymphoma with glomerulonephritis.

1986 | JOURNAL_ARTICLE

DOI: 10.1136/pgmj.62.734.1141

Mostrar Detalles

[Determination of exercise capacity in hypertensive subjects evaluated using ergometry]

1986 | JOURNAL_ARTICLE

Mostrar Detalles

Adult-onset Still's disease: a case with onset during pregnancy.

1985 | JOURNAL_ARTICLE

DOI: 10.1002/art.1780280819

Mostrar Detalles

[Pancreatitis associated with Salmonella enteritidis bacteremia]

1984 | JOURNAL_ARTICLE

Mostrar Detalles

Política de Cookies

Personalización de Cookies

Información ORCID de GIRON GONZALEZ, JOSE ANTONIO

Biografía

Educación

Máster en Enfermedades Infecciosas

Doctor en Medicina

Especialista en Medicina Interna (Medicina Interna)

Licenciatura de Medicina y Cirugía

Empleo

Jefe de Servicio (Medicina Interna)

Catedrático de Universidad (Medicina)

Facultativo Especialista (Medicina Interna)

Profesor Titular de Universidad (Medicina)

Facultativo Especialista (Medicina Interna)

Facultativo Especialista (Medicina Interna)

Obras

Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study

Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections

Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality

Assessment of the Palliative Prognostic Index in hospitalized oncologic patients treated by a palliative care team: impact of acute concomitant diseases.

Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.

Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Determination of glycosylated hemoglobin during hospitalization as an opportunity to assess and optimize glycemic control in our patients: An unresolved matter.

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.

Acute Q fever and the risk of developing endocarditis.

Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.

Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.

Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.

Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.

Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.

Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.

Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.

Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.

[Primary cutaneous nocardiosis caused by Nocardia farcinica].

[Use of an empirical antiretroviral treatment depends on the primary resistance rate of the human immunodeficiency virus].

[Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients].

Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.

Hepatocyte growth factor and chronic hepatitis C.

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.

[Neurocognitive impairment related to acquired immunodeficiency syndrome in socially-excluded former intravenous drug abusers].

Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.

Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.

An elderly woman with Prevotella bacteraemia secondary to pyometra.

Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.

[Progressive multifocal leukoencephalopathy in the province of Cadiz, Spain]

Bilateral pneumonia by Mycobacterium aurum in a patient receiving infliximab therapy.

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.

[Renal failure and insulin resistance: effect of the dialysis dose]

[Clinical and therapeutic management of respiratory tract infections. Consensus document of the Andalusian Infectious Diseases Society and the Andalusian Family and Community Medicine Society].

Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study.

Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.

What length of follow-up in patients with HIV and hepatitis C virus coinfection is necessary to consider the level of transaminases to be "persistently normal"?

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.

T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.

Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C.

Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.

Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha.

Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.

Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

Adhesion molecules as a prognostic marker of liver cirrhosis.

[Admissions and mortality changes in a third-level care Hospital Internal Medicine Department (1996-2000). Influence of the modifications in the HIV infection treatment]

Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.

Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon.

Implication of inflammation-related cytokines in the natural history of liver cirrhosis.

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

**Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality**